LRP1-tau interactions and Alzheimer Disease
LRP1-tau 相互作用与阿尔茨海默病
基本信息
- 批准号:10274154
- 负责人:
- 金额:$ 238.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAlzheimer&aposs disease patientApolipoprotein EAreaAxonBindingBinding ProteinsBrainBrain regionCell LineCell surfaceCellsCharacteristicsClinicalCollaborationsComplexCryoelectron MicroscopyCytoplasmDataDiseaseDisease ProgressionElementsEndocytosisEndosomesEnvironmental Risk FactorGeneticGrantHumanIndividualLDL-Receptor Related Protein 1LDL-Receptor Related ProteinsLaboratoriesLeadLigand Binding DomainLigandsLipoprotein (a)LysosomesMAPT geneMediatingMicroscopyMutationNeural PathwaysNeurofibrillary TanglesNeuronsPaperPathogenicityPathologicPatternProcessProtein IsoformsProteinsPublishingRecording of previous eventsResidual stateResolutionRoleRuptureSeedsSignal TransductionSurfaceSymptomsSynapsesSystemTimeWorkdefined contributionentorhinal cortexexperimental studygenetic risk factorin vivomisfolded proteinmouse modelmutantneuron lossneuropathologypaired helical filamentrare variantreceptorreceptor internalizationrelating to nervous systemtau Proteinstau aggregationtau interactiontau-1traffickinguptake
项目摘要
Neurofibrillary tangles (NFTs) are one of the characteristic features of Alzheimer disease (AD) neuropathology.
They are made primarily of the microtubule associated protein tau (MAPT) that is highly phosphorylated,
mislocalized to the cytoplasm from the axon, and aggregated in a complex, dense −pleated sheet that are
paired helical filaments (PHFs) as determined by cryo-electron microscopy. The distribution of NFTs in the brain
is overwhelmingly consistent across cases of AD: NFT occur initially in the entorhinal cortex, then “spread” to
other limbic and association areas over more than a decade; this spread corresponds to the clinical symptoms
of the disease, and correlates with neuronal loss. It was recognized early on that the pattern of spread largely
followed neuroanatomical connections, and it was demonstrated that at least part of the reason for this could be
explained by propagation of misfolded tau across synaptic elements. Recently, it has been discovered that the
LDL receptor-related protein binds tau and participates in tau propagation. The Hyman and Strickland
laboratories have worked together on LRP1 related projects since 1993 and have collaborated to confirm these
observations. Using fractions isolated from AD patient brains, we confirm that LRP1-expressing cells, but not
LRP1-deficient cells, promote tau seeding, demonstrating that LRP1 mediated uptake can lead to escape of tau
proteopathic seeds into the cytoplasm. The mechanism(s) of how this occurs are currently not known and will
be investigated in Aims 1 and 3 of this grant. We also identified some residual uptake that we now show to be
due, in part, to SORL1, another apoE receptor that is implicated in trafficking, and – importantly- is also clearly
implicated in the genetics of AD. The role of SORL1 in tau uptake and processing will be examined in Aims 2
and 3). These data and new questions lead us to propose a multi-PI application to explore the following aims:
(1) Identify mechanisms by which LRP1 promotes proteopathic seeding of tau; (2) Define the contribution of
SORL1 and SORL1 mutants to tau proteopathic seeding; (3) Identify mechanisms responsible for the
endolysosomal escape and tau seeding
神经原纤维缠结是阿尔茨海默病(AD)神经病理学的特征之一。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRADLEY T. HYMAN其他文献
BRADLEY T. HYMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRADLEY T. HYMAN', 18)}}的其他基金
Discovery and development of apoE4 correctors for the treatment of Alzheimer's disease
发现和开发用于治疗阿尔茨海默病的 apoE4 校正剂
- 批准号:
10901029 - 财政年份:2023
- 资助金额:
$ 238.43万 - 项目类别:
MGH Diseases of Aging Pathway Via Stimulating Access to Research in Residency (MGH DAP StARR)
通过刺激住院医师研究参与 MGH 衰老途径疾病 (MGH DAP StARR)
- 批准号:
10592226 - 财政年份:2023
- 资助金额:
$ 238.43万 - 项目类别:
Multi-omic Brain Cell Atlas of Alzheimer's Disease Progression
阿尔茨海默病进展的多组学脑细胞图谱
- 批准号:
10461533 - 财政年份:2021
- 资助金额:
$ 238.43万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
10332246 - 财政年份:2019
- 资助金额:
$ 238.43万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
10378606 - 财政年份:2019
- 资助金额:
$ 238.43万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
9914193 - 财政年份:2019
- 资助金额:
$ 238.43万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
10620661 - 财政年份:2019
- 资助金额:
$ 238.43万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center P30 Diversity Supplement Gaona
马萨诸塞州阿尔茨海默病研究中心 P30 多样性补充剂高纳
- 批准号:
10522320 - 财政年份:2019
- 资助金额:
$ 238.43万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
10511260 - 财政年份:2019
- 资助金额:
$ 238.43万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 238.43万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 238.43万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 238.43万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 238.43万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 238.43万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 238.43万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 238.43万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 238.43万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 238.43万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 238.43万 - 项目类别: